Home › Dermatomyositis › Arizona
Dermatomyositis clinical trials in Arizona
4 studies for Dermatomyositis are looking for participants at sites in Arizona.
Cities in Arizona
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT06455449A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Arizona Arthritis & Rheumatology Research, PLLC, Glendale
- Neuromuscular Research Center, Phoenix
- Mayo Clinic Hospital, Phoenix
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Phoenix
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale, Glendale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06698796From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.